---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-023467"
form_type: "8-K"
ticker: "LIMN"
cik: "0001971387"
company_name: "Liminatus Pharma, Inc."
filed_at: "2026-03-04T23:59:59+00:00"
generated_at: "2026-05-15T21:50:54.696117+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Liminatus Pharma reduces stockholder quorum requirement from majority to one-third

## Summary
- Board approved bylaw amendment reducing quorum from majority to one-third of voting power.
- Amendment effective immediately upon Board adoption on February 27, 2026.
- Bylaw amendment to be submitted for stockholder ratification at next annual meeting.

## SEC filing metadata
- accession: 0001104659-26-023467
- form_type: 8-K
- ticker: LIMN
- cik: 0001971387
- company_name: Liminatus Pharma, Inc.
- filed_at: 2026-03-04T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1971387/000110465926023467/0001104659-26-023467-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1971387/000110465926023467/tm267974d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-023467
- JSON: https://secwatch.observer/filing/0001104659-26-023467.json
- Plain text: https://secwatch.observer/filing/0001104659-26-023467.txt

## Source-grounded claims
- claim_id: e382cf8a0ce58f16872be174347e88748a3bb273
  claim: Liminatus Pharma, Inc.: Reduced stockholder meeting quorum requirement from majority to one-third of voting power (effective 2026-02-27).
  evidence_excerpt: On February 27, 2026, the Board of Directors (the “Board”) of Liminatus Pharma, Inc. (the “Company”) approved an amendment to the Company’s bylaws (the “Bylaws”) to reduce the quorum requirement for meetings of the stockholders from a majority to one-third (1/3) of the voting power of the capital stock of the Company issued and outstanding and entitled to vote (the “Bylaw Amendment”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1971387/000110465926023467/0001104659-26-023467-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.